Navigation Links
Cephalon Signs Option Agreement to Acquire Ception Therapeutics
Date:1/13/2009

Promising Monoclonal Antibody In Late- Stage Clinical Trial for the Treatment of Pediatric Eosinophilic Esophagitis

FRAZER, Pa. and MALVERN, Pa., Jan. 13 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) and Ception Therapeutics, Inc., a privately held biopharmaceutical company, today announced that the companies have signed an agreement providing Cephalon with an option to purchase all outstanding capital stock of Ception. Under the terms of the option agreement, Cephalon will pay Ception a $100 million upfront option payment.

Ception's lead product is reslizumab. Reslizumab is a humanized monoclonal antibody (mAb) against interleukin-5 (IL-5) currently in a Phase IIb/III clinical trial for the treatment of pediatric eosinophilic esophagitis (EE) and in a Phase II clinical trial for the treatment of eosinophilic asthma in adults. Ception also has an established program to discover small molecule, orally-active, anti-TNF (tumor necrosis factor) receptor agents.

Cephalon may exercise its option at any time prior to expiration of a specified period after receipt of the final study report for the pediatric EE clinical trial. If Cephalon exercises its option, the company will purchase all of the outstanding capital stock of Ception for $250 million. Ception shareholders could receive additional payments related to clinical and regulatory milestones.

"This deal builds on our heritage as a biotech company and creates the opportunity for Cephalon to introduce its first biologic into the market," said Frank Baldino, Jr., Ph.D. chairman and CEO of Cephalon. "The addition of biologics, which have a longer commercial life, will add higher value products to our portfolio. Strategically the agreement aligns with our development of prod
'/>"/>

SOURCE Cephalon, Inc.; Ception Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
7. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
8. New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
9. New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
10. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
11. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: ... webcasting its corporate presentation at the Cantor Fitzgerald Healthcare Conference ... Russell Cox , executive vice president ... company and a business and financial update on Wednesday, July ... A live audio webcast of the presentation ...
(Date:7/1/2015)... , June 24, 2015 ... has announced the addition of the ... and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, ... 2015 New Frontiers in European ... Emerging Technologies, Competitive Landscape is a new ...
(Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 22015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3
... AUSTIN, Texas, June 29, 2011 Ascension Orthopedics, Inc., the ... the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard ... "The patient was a 57-year-old, active male with ... by a fall from a mountain bike and not improved ...
... 2011 Medicines can cure disease, relieve symptoms, and ... a lot of damage if taken incorrectly, when not ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Studies estimate that up ... be prevented. Learn how FDA—through its Safe ...
Cached Medicine Technology:Ascension Orthopedics Implants PyroTITAN™ in Geelong, Australia 2
(Date:7/1/2015)... , ... July 01, 2015 , ... For decades, researchers ... wound, histones, remain constant in the brain, never changing after development in the womb. ... histones are steadily replaced in brain cells throughout life – a process which helps ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... today announced that they will welcome four new members to their industry leading ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... technology and services, today announced that its fifth annual Smile for a Lifetime ... $80,000 for the non-profit organization. In addition to supporting S4L in its mission ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... a new extraction plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of ... the DIC Group’s U.S. Spirulina* production base, began in May 2014. After commissioning, ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families (CCF) ... The grant will allow CCF to improve quality of care and save costs for ... to respond to many changes in New York’s Medicaid system. Experts agree that children ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3
... Sellamuthu, has ordered distribution of AIDS/HIV awareness calendar to ... tea stalls, hair cutting saloons and Indian Made Foreign ... large number of public gather. The idea of AIDS ... Control Society (TANSACS), according to the officials the calendar ...
... smokers or those who have been smoking in the past have ... tomography (CT scan) to detect // lung cancer if any, ... effective treatment and thereby improve the prognosis. ,The ... family history of the dreadful disease. For those of you ...
... to effective weight loss apart from diet and exercise. ... several myths abound // . Let’s throw some light ... and dispel famous myths to reveal underlying truths!, ,Body ... happens when calorie intake exceeds calories expended. The extra ...
... doctors of Indian origin live in a state of penury in ... of them even have decent // lodgings. This is the ... to serve in the country in 2001, which had resulted in ... ,Most of them are faced with discrimination and unemployment ...
... made news recently due to its wide spreading nature across the ... its // spread across the country. It ... reduced and area, which has been infected with the avian flu, ... that previously there were21 provinces affected with bird flu but now ...
... now proven by research. Apparently genuine laughter is the ... Review of Biology//. ,The study, which explains how ... that there are two types of laughter – genuine and ... second, is strategic and, at times, downright cruel, also nicknamed ...
Cached Medicine News:Health News:CT Scan A Must For Smokers With Family History Of Lung Cancer 2Health News:The weight loss reality check – Do Fad diets and short-cut methods actually work 2Health News:Genuine Laughter Is The Best Medicine! 2
... technology - Until now, if you wanted ... some of your patients while continuing to ... of patients, you had to keep a ... that has changed with Lifecard 12 - ...
... This direct fluorescent assays ... immunofluorescence technique to provide clear, ... 15 minutes. Chlamydia antigens ... antibody to the C. trachomatis ...
Inquire...
... Brachytherapy loaders allow for efficient, easy ... Connectors to your customized plans at ... Bard loaders is the flexibility to ... flexibility of the patented SourceLink™ Connector ...
Medicine Products: